Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berruti

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Breast (Edinburgh, Scotland)|November 27, 2004
Management of neuroendocrine differentiated breast carcinomaA Berruti, A Saini, E Leonardo, et al.
Social Science & Medicine (1982)|May 17, 2005
Maternal and child health and family planning service utilization in Guatemala: implications for service integrationEric E Seiber, David R Hotchkiss, Jeffrey J Rous, et al.
Oncology Reports|February 22, 2001
Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II studyS Bretti, E Manzin, A Celano, et al.
Minerva Endocrinologica|March 1, 1995
Cytotoxic chemotherapy for adrenocortical carcinomaL Dogliotti, A Berruti, A Pia, et al.
The Journal of Urology|November 7, 2001
Metabolic bone disease induced by prostate cancer: rationale for the use of bisphosphonatesA Berruti, L Dogliotti, M Tucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patientsA Berruti, P Borasio, A Roncari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of diseaseA Berruti, M Tampellini, M Torta, et al.
The International Journal of Health Planning and Management|July 13, 2007
Addressing the phenomenon of bypassing in Albania: the impact of a primary health care strengthening interventionDavid R Hotchkiss, Linda Piccinino, Altin Malaj, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 14, 2004
Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancerA Mosca, L Dogliotti, A Berruti, et al.
Drugs|January 1, 1992
Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patientsL Dogliotti, R A Antonacci, E Pazè, et al.
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Breast (Edinburgh, Scotland)|November 27, 2004
Management of neuroendocrine differentiated breast carcinomaA Berruti, A Saini, E Leonardo, et al.
Social Science & Medicine (1982)|May 17, 2005
Maternal and child health and family planning service utilization in Guatemala: implications for service integrationEric E Seiber, David R Hotchkiss, Jeffrey J Rous, et al.
Oncology Reports|February 22, 2001
Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II studyS Bretti, E Manzin, A Celano, et al.
Minerva Endocrinologica|March 1, 1995
Cytotoxic chemotherapy for adrenocortical carcinomaL Dogliotti, A Berruti, A Pia, et al.
The Journal of Urology|November 7, 2001
Metabolic bone disease induced by prostate cancer: rationale for the use of bisphosphonatesA Berruti, L Dogliotti, M Tucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patientsA Berruti, P Borasio, A Roncari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of diseaseA Berruti, M Tampellini, M Torta, et al.
The International Journal of Health Planning and Management|July 13, 2007
Addressing the phenomenon of bypassing in Albania: the impact of a primary health care strengthening interventionDavid R Hotchkiss, Linda Piccinino, Altin Malaj, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 14, 2004
Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancerA Mosca, L Dogliotti, A Berruti, et al.
Drugs|January 1, 1992
Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patientsL Dogliotti, R A Antonacci, E Pazè, et al.
Pageof 15